| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tivozanib | GDSC1000 | pan-cancer | AAC | 0.1 | 0.004 |
| mRNA | BRD-K20514654 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.004 |
| mRNA | BRD-K48334597 | CTRPv2 | pan-cancer | AAC | 0.19 | 0.004 |
| mRNA | AZD8055 | CTRPv2 | pan-cancer | AAC | -0.097 | 0.005 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.006 |
| mRNA | 681640 | GDSC1000 | pan-cancer | AAC | -0.11 | 0.006 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.095 | 0.006 |
| mRNA | AC220 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.006 |
| mRNA | AR-42 | GDSC1000 | pan-cancer | AAC | 0.083 | 0.008 |
| mRNA | TW 37 | GDSC1000 | pan-cancer | AAC | -0.087 | 0.01 |